Related Experiment Video
Updated: Aug 7, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
Update on HIV-associated nephropathy
Sonal Navin Shah1, Cijiang John He, Paul Klotman
1Mount Sinai School of Medicine, New York, NY 10029, USA.
Purpose Of Review:
HIV-associated nephropathy is characterized by a constellation of pathologic findings including a collapsing glomerulopathy, tubular dilatation, and interstitial infiltration with leukocytes. This review summarizes some of the recent advances in our understanding of the gene products and signaling pathways that contribute to the pathogenesis of HIV-associated nephropathy.
Recent Findings:
Podocytes infected with HIV-associated nephropathy exhibit podocyte proliferation and de-differentiation. Restriction of HIV-1 transgene expression to the podocyte in a murine model supports the belief that podocyte infection is pivotal to the development of the disease. Recent studies have provided compelling in-vitro and in-vivo evidence that expression of the HIV-1 accessory gene nef is critical in altering the phenotype of mature podocytes and causing injury to these cells. An in-vitro study suggests that nef's effects in the podocyte appear to be mediated through Src kinase-dependent activation of the signal transducer and activator of transcription 3 and mitogen-activated protein kinase 1,2 signaling pathways.
Summary:
Recent evidence demonstrates that the viral protein nef plays a critical role in the development of HIV-associated nephropathy and provides a foundation for developing new therapeutic strategies for patients afflicted with this disease.
Related Concept Videos
Nephrotic Syndrome II : Assessment and Medical Management
Diabetic Nephropathy
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome III : Nursing Management
Retrovirus Life Cycles
Acute Kidney Injury IV: Diagnostic Studies and Prevention
